p37, the major protein of the extracellular enveloped form of vaccinia virus, is involved in the biogenesis of the viral double membrane and in egress of virus from the cell. p37 was expressed as a glutathione S-transferase fusion protein and was purified to homogeneity by silver staining using glutathione-agarose, Sephacryl S-200, and DEAE-cellulose chromatography. Incubation of p37 with phosphatidylcholine labeled in the fatty acyl side chains resulted in the production of multiple lipid products that were identified by thin layer chromatography and mass spectrometry as diacylglycerol, free fatty acid, monoacylglycerol, and lysophosphatidylcholine. Lipid-metabolizing activities colocalized with p37-containing fractions throughout the chromatographic steps. p37 also metabolized phosphatidylethanolamine efficiently, but it had less activity toward phosphatidylinositol and little or no activity toward phosphatidylserine. The purified enzyme also metabolized triacylglycerol to diacylglycerol but was inactive toward sn-1,2-diacylglycerol. p37 was also expressed in insect cells as a poly-His fusion protein; cell lysates and partially purified proteins also generated products expected from phospholipase C and A activities. Thus, p37 is a broad specificity lipase with phospholipase C, phospholipase A, and triacylglycerol lipase activities.
Vaccinia virus is a member of the Poxviridae, a family of large, complex DNA viruses that replicate in the cytoplasm of infected cells (1, 2) . The infectious virion may exist as an intracellular mature virion (IMV), 1 intracellular enveloped virus (IEV), or an extracellular enveloped virus (EEV). Forms of the virus having an outer envelope (IEV and EEV) are more infective than the IMV form. The outer envelope of the EEV contains 10 EEV-specific viral proteins (3, 4) including an abundant palmitoylated protein with a molecular mass of 37 kDa (p37) which is encoded by the virus. In infected cells, p37 becomes localized initially to the trans-Golgi network where it is associated with the cytosolic face of the organelle (5) . Viral egress first involves wrapping the IMV with Golgi-derived membrane to form the double membrane of the IEV. The outer layer subsequently fuses with the plasma membrane of the cell to release the EEV, which contains a single outer envelope membrane.
p37 plays a role in membrane biogenesis and/or membrane fusion. Deletion of the gene encoding p37 results in the failure to form the outer envelope and a resulting inability to produce extracellular virus (6) . The intact virus is also capable of cellto-cell transmission, and this function is also lost in the p37-deficient virus (6) . Finally, infected cells undergo fusion of their plasma membranes at low pH, and this fails to occur in the p37-deficient virus. These data imply a critical role for p37 in membrane biogenesis and/or processes requiring membrane fusion, but the mechanism for such a role is unclear. Early suggestions that p37 may provide a docking site for viral envelopment have received little experimental support (7, 8) , so the function of p37 remains an open question.
During the course of studies on phospholipase D, we and others (9, 10) have noted significant homology between a 17-amino acid region of p37 (residues 313-329) and a conserved region among phospholipases D, phosphatidylserine synthases, and cardiolipin synthases. This region, termed the HKD domain, is essential for the catalytic activity of phospholipase D (11) . The homology, together with the putative functions related to membrane biogenesis and fusion, prompted us to search for phospholipid-metabolizing activities of p37. Herein we demonstrate that the p37 viral protein has both phospholipase C and phospholipase A activities toward a variety of lipid substrates. We suggest that one or more of these activities are involved in the biological function of p37. C]arachidonyl-sn-glycerol, and tri- [9, H]oleate-glycerol were purchased from Amersham. Escherichia coli sn-1,2-diacylglycerol kinase was purchased from Calbiochem. Phospholipase A 2 (Naja naja venom), phospholipase B (Vibrio species), and phospholipase C (Bacillus cereus) were obtained from Sigma. Phospholipids were from Avanti Polar Lipids. Silica Gel 60 TLC plates were obtained from Merck. Antibody to p37 was made in rabbits using p37-GST protein expressed in E. coli and was used for Western blotting at a dilution of 1:10,000. The antiserum was recognized both p37-GST and p37-His 6 , but it did not detect GST itself.
EXPERIMENTAL PROCEDURES

Materials-L-␣-Dipalmitoyl-[2-palmitoyl-9,10-
Expression and Purification of p37-GST in E. coli-Expression of p37 protein was carried out as described previously (12) . The recombinant pGEX-2T plasmid was constructed by ligating the large EcoRI-BamHI fragment from the pGEX-2T vector (Pharmacia Biotech Inc.) with the p37 cDNA coding region obtained by polymerase chain reaction. The amino-terminal amplimer (CGTG2GATCCATGTGGCCATTTGCAT-CG) was designed to anneal to the p37 sequence and to introduce a BamHI site (the BamHI recognition and cleavage site is shown in bold with 2, and the ATG initiation codon is underlined). The carboxylterminal amplimer (GATG2AATTCTTAAATTTTTAACGATTT) was * This work was supported by National Institutes of Health Grant CA46508. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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designed to anneal to the p37 sequence and to introduce an EcoRI site (bold, with 2 designating the EcoRI cleavage site). The cDNA was purified using Wizard polymerase chain reaction preparations (Promega, Madison, WI) and was inserted into the unique EcoRI and BamHI cloning site of the pGEX-2T vector. The DNA sequence was confirmed to be correct using automated DNA sequencing (Applied Biosystems Inc., Foster City, CA). The recombinant vector encodes a fusion protein containing an amino-terminal GST domain followed by the p37 sequence. p37-GST was expressed in E. coli strain DH5␣ using freshly transformed cells. Routinely, 1-liter cultures in LB/ampicillin (50 g/ml) medium were grown at 37°C until the A 600 reached 0.6 and then induced with 0.1 mM isopropyl-1-thio-␤-D-galactopyranoside. The cultures were incubated at 37°C for an addition 4 h. Cells were harvested by centrifugation at 4,000 ϫ g for 15 min and kept frozen at Ϫ80°C until purification.
Purification and Storage of p37-GST-Cell pellets from a total of 4 liters of culture were routinely used. The cells were thawed on ice and lysed by sonication in a buffer consisting of phosphate-buffered saline (127 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 ), pH 7.3, 8% sucrose, 1 mM EDTA, 2 mM dithiothreitol, phenylmethylsulfonylfluoride, leupeptin, aprotinin, pepstatin, and diisopropylfluorophosphate. The sonicated cells were centrifuged at 15,000 ϫ g for 10 min to remove cell debris. The p37-GST was adsorbed onto glutathione-agarose beads (Sigma), washed with 20 mM Tris-HCl buffer, and eluted with 10 mM glutathione. The eluate was dialyzed at 4°C in 20 mM Tris-HCl buffer, pH 7.3, to remove glutathione. The dialyzed p37-GST was concentrated using a Centricon-10 microconcentrators. p37-GST was purified by this single step to greater than 90% homogeneity as judged by Coomassie staining of SDS gels, with the major contaminant being free GST. For further purification, the protein was concentrated to 1 ml using a Centricon-10 microconcentrator, loaded onto a Sephacryl S-200 column (2.5 ϫ 50 cm) preequilibrated with 20 mM Tris-HCl buffer, pH 7.3, and eluted with a same buffer. Fractions (1 ml) were collected, and aliquots were analyzed by SDS-polyacrylamide gel electrophoresis for p37-GST protein and phospholipase activity. Fractions containing p37-GST were loaded onto a DEAE-cellulose column (2.5 ϫ 10 cm) and eluted in the same buffer with a gradient of 0 -1 M NaCl. Fractions (1 ml) were collected, and aliquots were analyzed by SDS-polyacrylamide gel electrophoresis followed by silver staining and activity assays. We initially experienced considerable problems with lability of the p37 activities. We found that activity could be preserved if the above procedures are carried out rapidly and if the p37 is stored in 20 mM Tris-HCl buffer, pH 7.3, containing 15% glycerol at Ϫ80°C.
Expression of p37-His 6 in Insect Cells-Primers were designed to anneal to the 5Ј-and 3Ј-ends of the p37 cDNA sequence and to introduce BamHI and PstI restriction sequences. The DNA was purified as above and inserted into the unique BamHI and PstI restriction sites of the pBlueBacHis2,C transfer vector. Recombinant baculovirus was obtained by cotransfecting the recombinant vector along with Bac-N-Blue AcMNPV baculovirus DNA as detailed in (13) . Recombinant plaques were identified by their development of blue color with 5-bromo-4-chloro-3-indolyl-␤-D-galactoside. The recombinant virus was plaque purified and amplified by several rounds of infection in Hi-5 insect cells. Cell lysates were prepared from uninfected or infected Hi-5 cells 3.5 days after infection with recombinant baculovirus and were used to test for the effect of p37 expression on enzymatic activity. p37 was partially purified using affinity chromatography on Probond resin (Invitrogen). Affinity chromatography was carried out according to the manufacturer's instructions except that Triton X-100 was omitted because of its strong inhibitory effect on p37 activities.
Assays for Phospholipase Lipid Products-Phospholipase activities were measured essentially as described previously (14 -16) . p37-GST (20 g/ml) was added to lipid substrate in the form of sonicated phospholipid in a total volume of 150 l of assay buffer (50 mM HEPES, pH 7.5, 3 mM EGTA, 80 mM KCl, 2.5 mM MgCl 2 , and 1.67 mM CaCl 2 ). For phosphatidylcholine hydrolysis, phospholipid vesicles were composed of phosphatidylethanolamine:phosphatidylcholine (16:1 mol/mol) containing L-␣-dipalmitoyl-[2-palmitoyl-9,10-3 H]phosphatidylcholine (0.25 Ci) to give about 250,000 cpm/assay. The mixture was incubated at 37°C for 1 h before the addition of 1 ml of CHCl 3 F:CH 3 OH:HCl (50:50:3 v/v). 1 M HCl amd 5 mM EGTA (0.35 ml) were then added to separate phases. The organic phase was dried (speed vacuum centrifugation), and lipids were resuspended in 40 l of CHCl 3 :CH 3 OH:CH 3 COOH (90:10:10 v/v). Aliquots were applied to thin layer silica gel plates (Silica Gel 60 F-254, Merck) which were developed in the same solvent. After drying, radioactivity was quantified using a Bio-scanner (Bioscan Inc., Washington, D. C.) equipped with two-dimensional analysis software. Lipid products were identified by comparison of R F values with those of standards that were generated from the same parent lipids using commercially obtained phospholipase C, phospholipase B, and phospholipase A 2 . The lipid product formed is expressed as the percentage of total counts in each lane. For analyzing the hydrolysis of other phospholipids, the phosphatidylcholine (both labeled and unlabeled) was replaced with the lipid to be investigated, and vesicles were prepared as above. The identity of lipid products was confirmed using fast atom bombardment (FAB) and liquid secondary ion mass spectrometry in the FABϩ and FABϪ modes. Glycerol was used as the matrix for FABϪ, and 3-nitrobenzyl alcohol/LiI was used for the FABϩ mode. Negatively charged species including fatty acid were detected using the FABϪ mode, whereas neutral and positively charged species were more FIG. 1. Phospholipase activity of expressed p37-GST. Panel A, p37-GST proteins were expressed in E. coli, purified as described under "Experimental Procedures," and analyzed by SDS-polyacrylamide gel electrophoresis using a 12.5% gel that was stained with Coomassie Blue. readily detected using the FABϩ mode. Mass spectrometry was carried out in the Mass Spectrometry Center in the Department of Chemistry at Emory University.
Transphosphatidylation-In addition to looking for generation of phosphatidic acid, phospholipase D activity was investigated by looking for transphosphatidylation. Assays were conducted under the same conditions as above using fatty acyl chain-labeled phosphatidylcholine, except that 1.6% ethanol was included. In some experiments, phosphatidylinositol bisphosphate was included because known mammalian phospholipase Ds require this lipid (16 -18) . In these experiments the conditions used were those reported previously (16) . Neutrophil membranes plus cytosol were used as a positive control for phospholipase D activity, as described previously (14,-15) . Phosphatidic acid and phosphatidylethanol were quantified after separation by thin layer chromatography, as described above.
Phosphatidylcholine Headgroup Release-The assay for release of [ 3 H]choline phosphate was carried out as above except that headgrouplabeled phosphatidylcholine was used in place of fatty acyl-labeled lipid. The reaction buffer was 50 mM HEPES, pH 7.5, 3 mM EGTA, 1.67 mM CaCl 2 , 2.5 mM MgCl 2 , and 80 mM KCl. The reaction was incubated at 37°C for 1 h and was terminated with chloroform:methanol as described above. After mixing and centrifuging at 2,000 ϫ g for 5 min, an aliquot of the upper (aqueous) layer was removed and analyzed for 3 H by liquid scintillation counting. For separation of water-soluble choline metabolites, ion exchange chromatography on Dowex 50W columns was carried out as described by Cook et al. (19) . The methanolic aqueous phase was diluted to 5 ml with water, loaded onto the columns, and eluted with an additional 5 ml of water to elute glycerolphosphocholine. Choline phosphate was eluted with an additional 10 ml of water. Choline was eluted with 10 ml of 1 M HCl. Fractions (1 ml each) were collected, and the radioactivity of each fraction was determined by scintillation counting.
Assay for Hydrolysis of Neutral Lipids-For detection of triacylglycerol lipase and diacylglycerol lipase activities, vesicles (neutral lipid: phosphatidylethanolamine, 1:16 mol:mol) were prepared by sonication. Approximately 100,000 cpm of either [ 3 H]triolein or 1-stearoyl-2-[1-14 C]arachidonyl-sn-glycerol was included. The reaction was carried out in assay buffer (above) by incubating p37 with lipid vesicles for 60 min at 37°C. After extraction into chloroform as detailed above, the products were measured by TLC (CHCl 3 :CH 3 OH:CH 3 COOH, 90:10:10 v/v). Radioactivity was detected with using a Bio-scanner.
Phosphorylation of Diacylglycerol with Diacylglycerol Kinase-Diacylglycerol was enzymatically converted to phosphatidic acid using E. coli diacylglycerol kinase, as described previously (20, 21) . The substrate (either that generated from tri- [9,10- 3 H]oleate by the action of p37 or from 1-stearoyl-2-[1-
14 C]arachidonyl-sn-glycerol) was prepared in a sonicated phosphatidylethanolamine dispersion, as above, and was incubated with p37 (20 g/ml) in a total volume of 150 l of assay buffer (50 mM HEPES, pH 7.5, 3 mM EGTA, 1.67 mM CaCl 2 , 2.5 mM MgCl 2 , and 80 mM KCl) at 37°C for 1 h. E. coli diacylglycerol kinase (10 g/ml) plus 0.5 mM ATP were then added, and the incubation was continued for 1 h. The reaction was stopped by the addition of acidified chloroform methanol, and lipids were extracted and dried as described above. [ 3 H]Phosphatidic acid was resolved by TLC developed with CHCl 3 :CH 3 OH: CH 3 COOH (90:10:10 v/v) and was quantified as above.
Miscellaneous Methods-Protein concentrations were estimated by the assay of Bradford and Rubin (22) with bovine serum albumin as a standard. SDS-polyacrylamide gel electrophoresis was performed according to Laemmli (23) . Western blotting was carried out using the rabbit anti-p37 antibody in a dilution of 1:10,000. Blots were visualized using a peroxidase-conjugated second antibody and a nonisotopic chemiluminescent system (Amersham).
RESULTS
Expression and Identification of p37 as a Phospholipasep37 was expressed in E. coli as a GST fusion protein and was initially purified by adsorption and elution from glutathioneagarose followed by chromatography on Sephacryl S-200, as described under "Experimental Procedures." An essentially homogeneous preparation of p37-GST was obtained with a yield of about 0.25 mg/liter of culture. The major protein showed an apparent molecular mass of approximately 63 kDa, corresponding to the predicted size. Although the fusion protein is predicted to contain a thrombin proteolytic cleavage site between the GST and the p37, treatment of the fusion protein with a large excess of thrombin failed to release significant quantities of free p37 (not shown). Therefore, p37-GST was purified and characterized as the fusion protein.
Purified p37-GST was initially incubated with phospholipid dispersions containing phosphatidylcholine labeled in the headgroup. Using this method, radiolabel was released into the aqueous phase after chloroform:methanol extraction. During a 1-h incubation of p37-GST with labeled phosphatidylcholine in a phosphatidylethanolamine sonicated dispersion, approximately 30% of the labeled phosphatidylcholine was metabolized to a water-soluble product. With GST alone, no detectable headgroup release was seen. The released product cochromatographed with choline phosphate and not with choline using Dowex 50W chromatography, as described under "Experimental Procedures." These data indicate that p37 has phospholipase C activity.
To characterize further the phospholipid-metabolizing activities of p37, the isolated fusion protein was incubated with phospholipid dispersions containing phosphatidylcholine that was labeled in the sn-2 fatty acyl side chain. As shown in Fig.   FIG. 2 . Concentration-and time-dependent activation of p37-GST activity. Panel A, experiments were carried out as described in the legend to Fig. 1 . L-␣-Dipalmitoyl-[2-palmitoyl-9,10- 1B, lane 4, p37 converted the phosphatidylcholine (Origin spot) into four major lipid products. By comparison with standards, these were identified as diacylglycerol (the expected product of phospholipase C), free fatty acid, monoacylglycerol, and lysophosphatidylcholine. Thus, in addition to a phospholipase C activity, p37 appeared to contain a phospholipase A activity(ies). The activities of p37 are illustrated by comparison with known lipases. Lane 1 contained phospholipase A 2 (N. naja); lane 2, phospholipase B (Vibrio species); and lane 3, phospholipase C (B. cereus). Phospholipases A 2 and B both produced free fatty acid, whereas phospholipase C produced diacylglycerol. Because the phospholipid was labeled in the sn-2 position, only phospholipase B, which can cleave a fatty acid from the sn-1 position, produced labeled lysophosphatidylcholine. p37 produced diacylglycerol, free fatty acid, and lysophosphatidylcholine as well as monoacylglycerol, which was also produced by the phospholipase B preparation, possibly because of a contaminant in the commercial preparation. Because p37 produces both labeled fatty acid and labeled lysophosphatidylcholine from phosphatidylcholine (labeled in the sn-2 fatty acid), this implies that the protein can catalyze both phospholipase A 2 and phospholipase A 1 reactions in an approximate ratio of 2:1. The generation of all four products was both time-and p37 concentration-dependent (Fig. 2, A and B, respectively) . Production of all lipid products was confirmed using mass spectrometry in the FABϩ and FABϪ modes. When pure dioleoylphosphatidylcholine was used as the substrate, only a small amount of product formation was noted, and this was primarily lysophosphatidylcholine and fatty acid. However, using phosphatidylethanolamine as substrate, products of the mass predicted for oleic acid, lysophosphatidylethanolamine, diacylglycerol, and monoacylglycerol were seen when p37 was present in incubations but not in control incubations. These data verify the use of thin layer chromatography and suggest that the enzyme may require phosphatidylethanolamine for optimal activity.
Phosphatidic acid (R F ϭ 0.3), a product of phospholipase D activity (Fig. 1B, lane 5) , was not seen upon incubation of phosphatidylcholine with p37. To test further whether phospholipase D activity was present, we carried out experiments in the presence of 1.6% ethanol, which would have generated phosphatidylethanol via transphosphatidylation (14, 15, 24) . This experiment was also carried out in both the absence and presence of phosphatidylinositol 4,5-bisphosphate (see "Experimental Procedures") because several phospholipase D activities have been reported to require this lipid (16 -18, 25) . In neither case was phosphatidylethanol detected. Thus, p37 has phospholipase A 1 , A 2 , and C activities, but no detectable phospholipase D activity.
Chromatography of p37-GST-It was possible that some of the observed activities were caused by contamination of p37 preparations with a bacterial lipase. However, preparations of GST lacking the fused p37 did not show any of the observed activities (data not shown). To verify further that the activities were associated with p37, we assayed for hydrolysis products during gel filtration chromatography. Fig. 3A shows the column profiles of lysophosphatidylcholine, fatty acid, and monoacylglycerol generation from phosphatidylcholine; Fig. 3B shows the release of the labeled choline headgroup into the aqueous phase. Fig. 3C shows a Coomassie Blue-stained SDS gel of aliquots of the column fractions. The larger band corresponds to the predicted size of p37-GST, whereas the smaller band corresponds in size to that predicted for GST alone (about 26 kDa). By Western blotting (not shown), both major bands were shown to react with antibody to GST, indicating that the major contaminant in the preparation is GST (without the fused p37), which may have been formed by proteolysis or premature termination. The major peak of activity was seen in fractions 31, 32, and 33, which corresponded to the major fractions containing p37-GST.
The peak fractions were chromatographed further on a DEAE-cellulose column (Fig. 4A) . Fractions 37-41 showed the highest levels of p37-GST by silver staining, and these were free of other detectable proteins (Fig. 4B) . The preparation lost much of its activity upon further chromatography, but some activity was still seen, and the generation of products correlated in general with the peak protein fractions. The loss in activity was not due to the presence of high salt, since high salt alone failed to inhibit activity.
To verify further that the observed activities were caused by the expressed protein and not a bacterial contaminant, p37 was expressed as an amino-terminal His 6 fusion protein in insect cells. Using phosphatidylcholine labeled in the headgroup, lysates from infected cells showed a significant increase in headgroup release compared with noninfected cells (Fig. 5, lanes 1  and 2) . Attempts to purify p37-His 6 by metal affinity chromatography resulted in only a roughly 2-fold purification of the protein, based on SDS-gel patterns (not shown). Because of the lability of the activity to detergents, Triton X-100 was omitted from the purification procedure, and this very likely resulted in the disappointing purification results. Nevertheless, the p37-enriched preparation (lanes 3 in Fig. 5) showed increased specific activity in headgroup release, and activity correlated with the presence of p37 determined by Western blotting (inset in Fig. 5A ). Using phosphatidylcholine labeled in the sn-2 fatty acid, lysates of infected cells again showed significant production of diacylglycerol and to a lesser degree, monoacylglycerol, compared with control lysates. The p37-enriched preparation showed a further increase in diacylglycerol-generating activity compared with control lysates. The phospholipase C specific activity of the p37 expressed in insect cells was approximately 30-fold higher than the activity of the bacterially expressed protein, based on normalization of activity to the amount of Fig. 3C were applied to a DEAE-cellulose column and eluted with a salt gradient as described under "Experimental Procedures." An aliquot (50 l) of each 1-ml fraction was incubated with L-␣-dipalmitoyl-[2-palmitoyl-9,10-3 H]phosphatidylcholine, and the 3 H products were analyzed by TLC, as in Fig. 1 . Abbreviations are as in Fig. 1 . Panel B, an aliquot (30 l) of each column fraction was mixed with a 10-l volume of 4 ϫ Laemmli SDS sample buffer, and 20 l of this was subjected to SDS-polyacrylamide gel electrophoresis using 12.5% acrylamide gels; protein was visualized using silver staining. MW, molecular weight.
FIG. 5.
Phospholipase activity of expressed p37-His 6 . p37-His 6 was expressed in insect cells using recombinant baculovirus as described under "Experimental Procedures." p37-His was enriched about 2-fold by binding to a Probond column, as described under "Experimental Procedures." Panel A, samples were analyzed for their ability to catalyze headgroup release, using phosphatidylcholine labeled in the headgroup, as described under "Experimental Procedures." Columns 1 and 2 show headgroup release activity present in lysates from sonicated control and infected insect cells, respectively; column 3 shows the activity of the p37-His 6 -enriched sample. 1 g of protein was used for each assay. The inset shows Western blots of SDS gels obtained using these same samples. 10 g of total protein was loaded in each lane. Panel B, samples were analyzed for their ability to generate lipid-soluble hydrolysis products from phosphatidylcholine that was radiolabeled in the sn-2 fatty acid. 1 g of lysates or p37-enriched fractions was used. Products were analyzed as in Fig. 1 by TLC, and products are identified in the figure. Abbreviations are as in Fig. 1.   FIG. 6 . Substrate specificity of p37-GST. p37-GST activities were assayed as described under "Experimental Procedures." All phospholipid substrates tested contained the label (either 3 H or 14 C) in the sn-2 fatty acid. Incubations, lipid extractions, and analyses by TLC were carried out as in Fig. 1 and under "Experimental Procedures." Results are the means Ϯϩ S.D. of three independent experiments and are expressed as percentages of total counts in each TLC lane. Abbreviations are as in Fig. 1 . expressed p37 protein (detected by Western blotting). This may indicate either that the presence of the GST domain is partially inhibitory or that more correct folding or processing of the protein occurs in the insect cells.
Substrate Specificity of p37-The ability of p37-GST to catalyze the hydrolysis of various glycerophospholipids was investigated. Phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol, all labeled in the sn-2 fatty acyl side chain, were used as substrates in the presence of unlabeled phosphatidylethanolamine as a carrier lipid. Labeled phosphatidylethanolamine using phosphatidylcholine as a carrier lipid was also used and gave essentially identical results (data not shown). Using substrates labeled in the sn-2-fatty acyl side chains, p37 caused product formation not only from phosphatidylcholine but also from phosphatidylethanolamine and to a lesser extent from phosphatidylinositol (Fig. 6) . Fatty acid and diacylglycerol were the major products form phosphatidylethanolamine, and minor amounts of monoacylglycerol were seen. Free fatty acid was the major product from phosphatidylinositol. Interestingly, lysophospholipid production was seen only with phosphatidylcholine, suggesting that phospholipase A 2 rather than phospholipase A 1 (which would produce labeled fatty acid and unlabeled lysophosphatidic acid) was the predominant fatty acidhydrolyzing activity when phosphatidylethanolamine and phosphatidylinositol were used as substrates. In terms of total product formation, phosphatidylcholine was the preferred substrate, with 74% of this phospholipid being converted to products compared with 53% for phosphatidylethanolamine and 12% for phosphatidylinositol.
Triacylglycerol-metabolizing Activity of p37-Using glycerol tri- [9,10- 3 H]oleate as a substrate, p37 stimulated a significant increase in [ 3 H]diacylglycerol and 3 H-labeled fatty acid from the labeled triacylglycerol (Fig. 7A) , indicating a triacylglycerol lipase activity. As with phosphatidylcholine metabolism, lipid product generation was dependent on p37 concentration (not shown). To determine whether the diacylglycerol that was produced included sn-1,2-diacylglycerol, we added diacylglycerol kinase, which converts the sn-1,2 isomer to phosphatidic acid, after incubation of p37 with labeled triacylglycerol. In this experiment, approximately half of the diacylglycerol was converted further to phosphatidic acid (Fig. 8A) . In a parallel control experiment using unlabeled triacylglycerol, labeled diacylglycerol that was added after the incubation with p37 was completely converted to phosphatidic acid in the presence of added diacylglycerol kinase (Fig. 8B) . These data indicate that a portion, but not all of the diacylglycerol that is generated by p37 is sn-1,2-diacylglycerol, with the remainder likely being one or more other isomers. When 1-stearoyl-2-[1-
14 C]arachidonyl-sn-glycerol was used as a substrate, the possible lipid products (monoacylglycerol and/or free fatty acid) were not detected (Fig. 7B) , indicating that p37 has no activity toward sn-1,2-diacylglycerol.
DISCUSSION
This study has identified broad specificity lipase activity associated with the vaccinia virus protein p37. The activities that have been demonstrated are summarized in Fig. 9 , which shows the metabolism of phosphatidylcholine and triacylglycerol. In this figure, p37 contains a phospholipase C as well as a phospholipase A activity (both PLA 1 and PLA 2 ) toward phosphatidylcholine. In addition to the four products produced by these activities (diacylglycerol, choline phosphate, lysophosphatidylcholine, and free fatty acid), p37 also produces monoacylglycerol. As shown in Fig. 9 (dashed line), we presume that this derives from lysophosphatidylcholine by cleavage of the headgroup in a phospholipase C-like reaction. The other possible route to this product would be through hydrolysis of diacylglycerol. However, this reaction fails to occur in vitro, implicating the former mechanism of formation. Also shown in Fig. 9 is the metabolism of triacylglycerol to diacylglycerol plus fatty acid. This reaction fails to produce monoacylglycerol, consistent with the inability of p37 to metabolize diacylglycerol further. In addition to phosphatidylcholine, the phospholipase activities can utilize both phosphatidylethanolamine and (to a lesser extent) phosphatidylinositol, although the product distribution differs somewhat depending on the phospholipid used. We were unable to detect any evidence for a phospholipase D type activity.
The occurrence of headgroup release and diacylglycerol generation in lysates from insect cells infected with baculovirus expressing p37-His 6 confirms the phospholipase C activity of p37. This fusion protein was significantly more active than the p37-GST protein in catalyzing the phospholipase C reaction. The occurrence of increased monoacylglycerol in lysates from infected cells can be taken as evidence confirming a phospholipase A-like reaction. The inability to observe lysophosphatidylcholine using p37-His 6 is consistent with the considerably higher phospholipase C activity of this version of the protein compared with p37-GST. We suggest (see Fig. 9 ) that any lysophosphatidylcholine that is formed is cleaved rapidly to monoacylglycerol via a (lyso)phospholipase C activity. The product distribution seen with p37-His 6 raises the distinct possibility that the quantitatively most important activity in vivo is phospholipase C acting on both phosphatidylcholine and phosphatidylethanolamine. It will be necessary to express the protein in mammalian cells in its native palmitoylated form to evaluate fully these activities in their native settings.
The mechanism for this broad specificity lipase is unclear. There are features of p37 activity which are similar to those of hepatic and extrahepatic lipases, which are known to have broad substrate specificity for phospholipids, can also act on neutral lipids such as triacylglycerol, and do not require calcium (26) . However, we are not aware of a lipase of this type which catalyzes both phospholipase C and phospholipase A type activities (phosphodiesterase and acylesterase). It is possible that there are two distinct active sites on p37. This is consistent with the presence of duplication of three distinct regions within p37, which are suggestive of gene duplication 2 (27). Members of the phospholipase D family also contain these homologous duplicated regions, including the HKD region, which is found in both the amino-and carboxyl-terminal halves of phospholipase Ds. However, mutation of either HKD region results in complete loss of activity of PLD2 (11) , suggesting that at least for phospholipase D, both regions cooperate in forming the PLD active site.
The region of p37 which is most similar to phospholipase D is the (H)KD motif (9, 10, 27). p37 contains an internal repeat of this region, but its first occurrence is divergent from and bears little overt resemblance to a conventional HKD motif. The motif beginning at residue 312 of p37 bears a striking homology to the HKD motif of phospholipase D1 and other homologs. However, all of the known phospholipase Ds reportedly have a histidine at the beginning of this sequence (ૺ in motif 1), and this residue is lacking in p37 (9) . To test whether it was possible to transmute p37 into a phospholipase D, we have mutated Asn-312 to a His. However, this mutation failed to alter the product distribution, and no evidence for a phospholipase D activity was seen. 3 The HKD region containing the conserved histidine is present in two other phospholipid-metabolizing enzymes, cardiolipin synthase and phosphatidylserine synthase, both of which (along with phospholipase D) catalyze phosphatidate transferase reactions. In addition, a distantly related endonuclease also contains this region, including the conserved histidine. In all of these enzymes, the HKD residues underlined in Motif 1 are highly conserved and have been suggested to act as a catalytic triad, with the aspartate functioning as the nucleophile to attack the scissile bond (9) . This aspartate is conserved in p37 and might function in some modified manner to produce the observed hydrolytic reactions. Alternatively, the histidine has been suggested to function in the formation of the covalent intermediate with the phosphorus, by analogy with histidinephosphorus intermediates formed, e.g. by nucleoside diphosphate kinase (28) . The lack of this histidine might be of significance in the failure to note a phospholipase D activity. Finally, calcium-independent phospholipase As utilize an Asp-His-Ser triad that presumably works in a manner similar to serine proteases to activate the serine that forms the fatty acyl-enzyme intermediate. Although phospholipase Cs that work on inositol lipids utilize a hydroxyl from the inositol ring for nucleophilic attack on the phosphorus (resulting in a cyclic phosphodiester intermediate), less is known about the mechanism of phospholipase Cs that act on phosphatidylcholine. An active site serine would seem to be a likely participant in such a mechanism. We have mutated both the serine and the conserved aspartate (residues 327 and 319, respectively), but we have been unable to detect any effect on either the phospholipase activities of p37-GST. 3 Thus, it is possible that although p37 is evolutionarily related to phospholipase D and other phosphatidate transferases, it has diverged significantly in its function and mechanism. In one scenario, the phospholipid binding function has been retained, but critical active site(s) residues may be altered and/or are now provided by different regions of the protein.
The role of the catalytic activity in the in vivo function of p37 is currently unknown. The protein becomes incorporated into 2 J. D. Lambeth, unpublished results. 3 S.-H. Baek, unpublished results.
FIG. 8.
Diacylglycerol generated by p37-GST is converted to phosphatidic acid. Panel A, p37-GST (0.3 g/ml) was incubated with tri- [9,10- 3 H]oleate-glycerol at 37°C for 1 h. Half of the sample was then incubated with E. coli diacylglycerol kinase (DGK) (10 g/ml) along with 0.5 mM Mg 2ϩ -ATP, and the incubation was continued for 1 h at 37°C. A parallel incubation was continued under the same conditions without the addition of diacylglycerol kinase. Lipid products were then extracted and analyzed by TLC as described under "Experimental Procedures." DAG refers to diacylglycerol. In the first group (Ϫ), no p37 was added. Panel B, the p37-GST was incubated with unlabeled triolein for 1 h at 37°C. 1-Stearoyl-2-[1-
14 C]arachidonyl-sn-glycerol was then added either with or without diacylglycerol kinase plus Mg 2ϩ -ATP, as in panel A, and the incubation was continued for an additional hour before extraction and analysis of lipids as described in under "Experimental Procedures." the cytosolic face of trans-Golgi membranes and might be involved in somehow redirecting Golgi membranes from their normal fates to the virus, where they participate in enveloping the virion in a double membrane. Virus that lacks p37 fails to mature to the enveloped stage, and infected cells fail to fuse with one another (6) . These data suggest that p37 may function in processes involving membrane fusion. In this regard, it is interesting to note that diacylglycerol, lysophosphatidic acid, and free fatty acid have all been described as lipids that induce membrane fusion (29 -33 ). An important recent study with the yeast phospholipid transfer protein Sec14 (which had previously linked phospholipid metabolism to Golgi vesicle trafficking) implicated diacylglycerol as an essential component in vesicle-mediated transport from Golgi (34) . In addition, phosphatidic acid, which can be formed not only directly via phospholipase D but also secondarily from diacylglycerol by the action of cellular diacylglycerol kinase, has been implicated in the Arf-dependent recruitment of coatamer to budding Golgi to form transport vesicles (35) . Proof of the role for p37 lipase activities in viral envelopment and membrane biogenesis must await identification of the active site(s) and demonstration that crippling the activities correlated with a loss in viral envelopment and release. Such studies are currently under way.
Other viruses may utilize similar mechanisms as part of their life cycles. Perez et al. (36) reported that during the infection of HeLa cells with Semliki forest virus, or baby hamster kidney cells with vesicular stomatitis virus, there is a significant increase in the release of choline phosphate and arachidonic acid into the culture medium, suggesting that both phospholipases C and A become activated during infection. To our knowledge, there are no similar data for poxvirus infections. Little is known about the molecular mechanism used by viruses to alter membrane structures. The specific viral components responsible for these modifications have not been identified, nor have their effects on cells been analyzed. Our data raise the possibility that p37 may be such a component in pox viruses.
